RPMI-8226/RFP Stable Cell Line

Description

RPMI-8226/RFP Stable Cell Line is a genetically engineered human multiple myeloma model derived from RPMI-8226 cells through stable integration of red fluorescent protein (RFP). This engineered cell line maintains characteristic plasma cell morphology and retains native multiple myeloma markers (CD38, CD138) while exhibiting strong constitutive RFP expression for real-time cell tracking. The bright red fluorescence enables non-invasive monitoring of tumor cell migration, metastasis, and engraftment in both in vitro and in vivo applications without requiring exogenous staining. Particularly valuable for tumor microenvironment studies and drug screening assays, this cell line allows longitudinal tracking of tumor progression through fluorescence imaging. Cryopreserved at low passage (<P20) to ensure stable RFP expression and genetic integrity. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast and Bacteria.